Kistler Andreas
Biological Pharmaceutical Research Department, F. Hoffmann-La Roche & Co. Ltd., CH-4002, Basle, Switzerland.
Wilehm Roux Arch Dev Biol. 1984 May;193(3):121-126. doi: 10.1007/BF00848886.
In fetal rat bones in culture the divalent cation ionophore A23187 inhibited in a dose-dependent manner both the release of proteoglycans and the subsequent degradation of cartilage induced by retinoic acid, indicating that calcium was involved in its action. A23187 had to be present continuously to manifest its inhibitory effect; retrieval of the ionophore abolished the suppression, demonstrating that the effect was reversible and not due to toxicity. A23187 at 1.0 μM, which completely blocked the retinoic acid-induced cartilage resorption, markedly suppressedH-leucine,H-mannose andH-thymidine incorporation in control and retinoic acid-treated cultures. ReducedH-thymidine incorporation did not appear to be responsible for the inhibition by A23187 of retinoic acid-induced cartilage resorption because inhibitors of DNA synthesis did not affect the retinoic acid response. In the presence of retinoic acid the ionophore at 0.3 μM had no effect on the incorporation ofH-leucine andH-mannose, but suppressed the retinoic acid-induced proteoglycan release. This suggests that reduced protein and glycoprotein synthesis were not the main causes for the inhibitory effect of A23187. In conclusion, retinoic acid-induced cartilage degradation required calcium at some crucial points.
在培养的胎鼠骨骼中,二价阳离子载体A23187以剂量依赖的方式抑制蛋白聚糖的释放以及随后由视黄酸诱导的软骨降解,这表明钙参与了其作用。A23187必须持续存在才能发挥其抑制作用;去除离子载体后抑制作用消失,这表明该作用是可逆的,并非由毒性引起。1.0 μM的A23187完全阻断了视黄酸诱导的软骨吸收,显著抑制了对照培养物和视黄酸处理培养物中³H-亮氨酸、³H-甘露糖和³H-胸腺嘧啶核苷的掺入。³H-胸腺嘧啶核苷掺入减少似乎不是A23187抑制视黄酸诱导的软骨吸收的原因,因为DNA合成抑制剂不影响视黄酸反应。在视黄酸存在的情况下,0.3 μM的离子载体对³H-亮氨酸和³H-甘露糖的掺入没有影响,但抑制了视黄酸诱导的蛋白聚糖释放。这表明蛋白质和糖蛋白合成减少不是A23187抑制作用的主要原因。总之,视黄酸诱导的软骨降解在某些关键环节需要钙。